Results per Page:
Are we ready for multi-cancer detection tests?
Blood-based cancer tests are coming, but questions about efficacy, reimbursement and diagnostic pathways are far from settled
$600,000 in awards against ovarian cancer for Fred Hutch and UW researchers
Research awarded from the Rivkin Center and Andy Hill CARE fund will dramatically improve outcomes for ovarian cancer patients and the clinicians treating them
More than a fertility struggle? Infertility’s tie to ovarian cancer risk
From the Harris research group, Public Health Sciences Division
When her metastatic ovarian cancer kept returning, proton therapy was a patient’s last hope
10 years after proton therapy, Charlotte Elwood is thriving and encourages others to never give up
New deputy CMO brings Texas-sized expertise to Fred Hutch
Dr. Nicole Fleming takes over daily operations of South Lake Union clinic that has grown by 30% in three years
The link between intimate care products and ovarian cancer
From the Harris research group, Public Health Sciences Division
$400,000 awarded to ovarian cancer researchers
Drs. Holly Harris and Elizabeth Swisher receive Rivkin Center, Andy Hill CARE Fund grants to pursue prevention methods
New techniques, collaborations push patient-focused precision oncology forward
$5.4M NCI award supports Dr. Chris Kemp’s multi-disciplinary discovery platform for cancer-therapy targets
BRCA-mutation researcher Dr. Rosevalentine Bosire named Brave Fellow
In memory of runner Gabe Grunewald, research at Fred Hutch will inform new treatments for rare and aggressive cancers
One step closer to personalized oncology for chemo-resistant ovarian cancer
From the Paulovich Lab, Translational Science and Therapeutics Division
Big-picture approach helps identify experimental diagnostic to personalize ovarian cancer treatment
Team uses large-scale proteogenomic changes to identify which patients should look beyond standard treatment options
Una clave de la metástasis del cáncer de mama se esconde en las diminutas cavidades entre las células
Del Laboratorio Cheung, Programa de cánceres de mama y ovario, Consorcio del cáncer.
Navigating a cancer diagnosis while pregnant
Rare genetic mutation leads to cancer, treatment and vigilant screening for family
When more is better: bevacizumab treatment for patients with ovarian cancer
From the Liao Group, Breast and Ovary Cancers Research Program, Cancer Consortium
Fred Hutch study highlights racial disparities in ovarian cancer risk for women
Researchers examined risks for Black and white women with endometriosis and fibroids to understand how common medical interventions for those conditions modified the outcomes
Examining factors that may impact ovarian cancer survival disparities
From the Harris Group, Public Health Sciences Division